Academia Sinica yesterday said that it has synthesized monoclonal antibodies that can identify the protein of the coronavirus that causes COVID-19, which it said is an important step toward producing a rapid screening reagent for the virus.
The potential reagent, if successfully mass produced, would shorten the testing time for COVID-19 from about four hours to 15 to 20 minutes, significantly improving screening efficiency, the nation’s top academic research institution said in a statement on Facebook.
Yang An-suei (楊安綏), an Academia Sinica research fellow at the Genomics Research Center who headed the team that synthesized the antibodies, said that for rapid screening to work, the reagent should accurately identify the new coronavirus.
Screen grab from Academia Sinica’s Facebook page
The team produced 46 monoclonal antibodies in just 19 days, with each sample weighing at least 1mg, based on seven human coronavirus nucleocapsid protein antigens, Yang said.
One of the antibodies has demonstrated “perfect” efficiency in identifying the new coronavirus, because it does not react to other members of the coronavirus family, including those that cause SARS and Middle East respiratory syndrome, Yang added.
Data about the antibodies would be placed on the COVID-19 platform the institute has built to share information with domestic academic and scientific research institutes to speed up the development of rapid screening kits, drugs and vaccines to combat the epidemic, Academia Sinica President James Liao (廖俊智) said.
Yang’s team achieved its goal two months ahead of schedule, Liao said.
Assisted by the Ministry of Economic Affairs, the research team would hold talks with several companies about the production of rapid screening kits based on the research results, Academia Sinica said.
If everything goes smoothly, mass production could begin soon after the Ministry of Health and Welfare verifies and approves the reagent, within the next three to four months, the institute said.
The disease has infected more than 100,000 people in more than 80 nations and territories, including Taiwan, and has killed more than 3,000 people since it was first reported in Wuhan, China, in December last year.
South Korean K-pop girl group Blackpink are to make Kaohsiung the first stop on their Asia tour when they perform at Kaohsiung National Stadium on Oct. 18 and 19, the event organizer said yesterday. The upcoming performances will also make Blackpink the first girl group ever to perform twice at the stadium. It will be the group’s third visit to Taiwan to stage a concert. The last time Blackpink held a concert in the city was in March 2023. Their first concert in Taiwan was on March 3, 2019, at NTSU Arena (Linkou Arena). The group’s 2022-2023 “Born Pink” tour set a
CPBL players, cheerleaders and officials pose at a news conference in Taipei yesterday announcing the upcoming All-Star Game. This year’s CPBL All-Star Weekend is to be held at the Taipei Dome on July 19 and 20.
The Taiwan High Court yesterday upheld a lower court’s decision that ruled in favor of former president Tsai Ing-wen (蔡英文) regarding the legitimacy of her doctoral degree. The issue surrounding Tsai’s academic credentials was raised by former political talk show host Dennis Peng (彭文正) in a Facebook post in June 2019, when Tsai was seeking re-election. Peng has repeatedly accused Tsai of never completing her doctoral dissertation to get a doctoral degree in law from the London School of Economics and Political Science (LSE) in 1984. He subsequently filed a declaratory action charging that
The Hualien Branch of the High Court today sentenced the main suspect in the 2021 fatal derailment of the Taroko Express to 12 years and six months in jail in the second trial of the suspect for his role in Taiwan’s deadliest train crash. Lee Yi-hsiang (李義祥), the driver of a crane truck that fell onto the tracks and which the the Taiwan Railways Administration's (TRA) train crashed into in an accident that killed 49 people and injured 200, was sentenced to seven years and 10 months in the first trial by the Hualien District Court in 2022. Hoa Van Hao, a
RSS